• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贲门失弛缓症的阿育吠陀疗法

Ayurvedic management of achalasia.

作者信息

Rastogi Sanjeev, Chaudhari Priyanka

机构信息

Department of Panchakarma, Annals of Ayurvedic Medicine, State Ayurvedic College and Hospital, Lucknow, Uttar Pradesh, India.

Editorial Office, Annals of Ayurvedic Medicine, State Ayurvedic College and Hospital, Lucknow, Uttar Pradesh, India.

出版信息

J Ayurveda Integr Med. 2015 Jan-Mar;6(1):41-4. doi: 10.4103/0975-9476.146556.

DOI:10.4103/0975-9476.146556
PMID:25878463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4395928/
Abstract

Achalasia is an esophageal motor disorder characterized by sustained lower esophageal sphincter contraction and reduced esophageal peristalsis. This pathology eventually results in symptoms like dysphagia, regurgitation and occasional chest pain related to food intake. This is an uncommon disorder of unexplained etiology; however viral, autoimmune and neurodegenerative causes are often afflicted to its manifestation. As per the current state of knowledge, achalasia is considered to be a chronic incurable condition. The treatment options offered here primarily aim at reducing the tone of lower esophageal sphincter by pharmacologic, endoscopic or surgical means. We are presenting here a case of achalasia with two years of symptomatic history of food regurgitation, dysphagia and heart burn without any noticeable response from allopathic medicines. The patient was subsequently kept under ayurvedic therapy considering the symptoms caused by vata impairment and hence requiring vatanulomana and reduction in esophageal muscle tone as the primary management. The patient was kept under suggested Ayurvedic therapy and followed-up for 3 months. A symptom-free follow-up in this case was noticed after completion of 1 month of Ayurvedic therapy.

摘要

贲门失弛缓症是一种食管运动障碍性疾病,其特征为食管下括约肌持续收缩以及食管蠕动减弱。这种病理状况最终会导致吞咽困难、反流以及偶尔与进食相关的胸痛等症状。这是一种病因不明的罕见疾病;然而,病毒、自身免疫和神经退行性病因常与其表现相关。根据目前的知识水平,贲门失弛缓症被认为是一种慢性不治之症。这里提供的治疗选择主要旨在通过药物、内镜或手术手段降低食管下括约肌的张力。我们在此呈现一例贲门失弛缓症病例,该患者有两年食物反流、吞咽困难和烧心的症状史,服用所有opathic药物均无明显反应。考虑到由风邪损伤引起的症状,因此需要进行风邪疏导并降低食管肌张力作为主要治疗方法,随后该患者接受了阿育吠陀疗法。该患者接受了建议的阿育吠陀疗法并随访了3个月。在完成1个月的阿育吠陀疗法后,该病例出现了无症状的随访结果。

相似文献

1
Ayurvedic management of achalasia.贲门失弛缓症的阿育吠陀疗法
J Ayurveda Integr Med. 2015 Jan-Mar;6(1):41-4. doi: 10.4103/0975-9476.146556.
2
Idiopathic (primary) achalasia: a review.特发性(原发性)贲门失弛缓症:综述
Orphanet J Rare Dis. 2015 Jul 22;10:89. doi: 10.1186/s13023-015-0302-1.
3
Achalasia: current therapeutic options.贲门失弛缓症:当前的治疗选择。
Ther Adv Chronic Dis. 2017 Jun;8(6-7):101-108. doi: 10.1177/2040622317710010. Epub 2017 Jun 23.
4
Achalasia: from diagnosis to management.贲门失弛缓症:从诊断到治疗。
Ann N Y Acad Sci. 2016 Oct;1381(1):34-44. doi: 10.1111/nyas.13176. Epub 2016 Aug 29.
5
Peroral endoscopic myotomy (POEM) for esophageal primary motility disorders: analysis of 100 consecutive patients.经口内镜下肌切开术(POEM)治疗食管原发性动力障碍:100例连续患者的分析
J Gastrointest Surg. 2015 Jan;19(1):161-70; discussion 170. doi: 10.1007/s11605-014-2610-5. Epub 2014 Sep 3.
6
Primary esophageal motility disorders.原发性食管动力障碍
Mayo Clin Proc. 2001 Feb;76(2):195-200. doi: 10.1016/S0025-6196(11)63127-3.
7
Idiopathic (primary) achalasia.特发性(原发性)贲门失弛缓症。
Orphanet J Rare Dis. 2007 Sep 26;2:38. doi: 10.1186/1750-1172-2-38.
8
Peroral endoscopic myotomy laparoscopic myotomy and partial fundoplication for esophageal achalasia: A single-center randomized controlled trial.经口内镜肌切开术、腹腔镜肌切开术和部分胃底折叠术治疗食管失弛缓症:一项单中心随机对照试验。
World J Gastroenterol. 2022 Sep 7;28(33):4875-4889. doi: 10.3748/wjg.v28.i33.4875.
9
ACG Clinical Guidelines: Diagnosis and Management of Achalasia.ACG 临床指南:贲门失弛缓症的诊断与管理。
Am J Gastroenterol. 2020 Sep;115(9):1393-1411. doi: 10.14309/ajg.0000000000000731.
10
Achalasia: current treatment options.贲门失弛缓症:当前的治疗选择
Expert Rev Gastroenterol Hepatol. 2015;9(8):1101-14. doi: 10.1586/17474124.2015.1052407.

引用本文的文献

1
Principle of Hot (Ushna) and Cold (Sheeta) and Its Clinical Application in Ayurvedic Medicine.热(乌莎那)和冷(希塔)的原则及其在阿育吠陀医学中的临床应用。
Adv Exp Med Biol. 2021;1343:39-55. doi: 10.1007/978-3-030-80983-6_4.
2
Ayurveda co-interventions have supported complete recovery in severe COVID-19 infection with a chest severity score 18/25: A case report.阿育吠陀辅助干预措施助力胸部严重程度评分为18/25的重症新冠肺炎感染患者实现完全康复:一例病例报告。
J Ayurveda Integr Med. 2022 Apr-Jun;13(2):100417. doi: 10.1016/j.jaim.2021.02.008. Epub 2021 Mar 12.

本文引用的文献

1
ACG clinical guideline: diagnosis and management of achalasia.ACG 临床指南:贲门失弛缓症的诊断和治疗。
Am J Gastroenterol. 2013 Aug;108(8):1238-49; quiz 1250. doi: 10.1038/ajg.2013.196. Epub 2013 Jul 23.
2
Development and validation of a Prototype Prakriti Analysis Tool (PPAT): Inferences from a pilot study.原型体质分析工具(PPAT)的开发与验证:一项试点研究的推论
Ayu. 2012 Apr;33(2):209-18. doi: 10.4103/0974-8520.105240.
3
Management of spastic disorders of the esophagus.食管痉挛性疾病的治疗。
Gastroenterol Clin North Am. 2013 Mar;42(1):27-43. doi: 10.1016/j.gtc.2012.11.002. Epub 2013 Jan 4.
4
2011 update on esophageal achalasia.食管失弛缓症 2011 年更新
World J Gastroenterol. 2012 Apr 14;18(14):1573-8. doi: 10.3748/wjg.v18.i14.1573.
5
Esophageal hypersensitivity.食管超敏反应。
Gastroenterol Hepatol (N Y). 2010 Aug;6(8):497-500.
6
Achalasia: update on the disease and its treatment.贲门失弛缓症:疾病及其治疗的最新进展
Gastroenterology. 2010 Aug;139(2):369-74. doi: 10.1053/j.gastro.2010.06.024. Epub 2010 Jun 18.
7
Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee.贲门失弛缓症的诊断与管理。美国胃肠病学会实践参数委员会
Am J Gastroenterol. 1999 Dec;94(12):3406-12. doi: 10.1111/j.1572-0241.1999.01639.x.